MedTrace Logo

Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study

NCT04057001 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2023-08-25

No results posted yet for this study

Summary

Compare wait list mortality and time to liver, heart or kidney transplant for registrants listed to consider allografts from Hepatitis C Virus (HCV) Nucleic Amplification Testing (NAT)+ donors versus those who are not . The umbrella protocol has been set up to include heart and kidney transplant recipients.

Conditions

  • Liver Transplant; Complications
  • Hepatitis C

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • AnnMarie Liapakis, MD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2023-03-06
Completion
2023-03-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04057001 on ClinicalTrials.gov